Two biotechnology companies in Australia have begun the first human trials of a vaccine for the 2009 H1N1 (swine flu) virus.
Adelaide-based Vaxine Pty Ltd and Melbourne-based CSL Biotherapies injected the first adult volunteers this week in separate trials starting days apart.
Now in its winter flu season, Australia has reported about 15,000 confirmed cases of the new H1N1 virus and 41 deaths. That has made Australian health officials and drug manufacturers anxious to get a vaccination program under way as soon as possible.
SWINE flu has recorded its deadliest day yet, with five more fatalities linked to the disease announced yesterday.
The number of Australians who have died with the novel AH1N1 virus jumped to 18, on the same day that health authorities revealed swine flu was now infecting more influenza patients than all other strains combined.
Link to The Australian